Science Translational Medicine is the leading weekly online journal publishing translational research at the intersection of science, engineering and medicine.
๐ Congratulations to Moran Amit, winner of the 2026 AAAS Martin and Rose Wachtel Cancer Research Award!
Sign up now for his lecture about his prize-winning work on how cancers reprogram nerves, which is 9 October at the @AAAS building and via livestream: https://t.co/EQsVF4MZv2
A new antifungal drug architecture combats infections in mice without the usual toxicity, a fluorescent imaging agent could enable more pinpointed removal of lung cancer tumors, and more in this week's new issue of #ScienceTranslationalMedicine. https://t.co/88pcdRXSzC
AI is transforming the discovery and design of #antibiotics but requires concurrent progress in data standards, validation pipelines, and regulation to reach patients, argues a new Viewpoint. @delafuentelab@Hanqun_CAO@MIT_IMES https://t.co/Lnzxd05z0k
In a new Editorial, researchers sound the alarm against the rising tide of rifampicin-resistant #tuberculosis and urge the need for an effective vaccine and control measures that integrate genomics and social interventions. @Unesp_Oficial@facfarmaciaUL https://t.co/x3886h2fxc
A new Viewpoint discusses how integrating modernized commercial models, genomic surveillance, streamlined trial design, advances in #AI, and other innovations can tackle the dangers of #AntibioticResistance. @GSK https://t.co/u3N86vcMsN
A small molecule therapy for #Alzheimers disease that activates #TREM2 in #microglia boosts the breakdown of amyloid-beta in neurons and mice and is well-tolerated in healthy individuals and patients, according to results from a phase 1 trial. @sanofi https://t.co/YwPOEeZXS5
A new Editorial stresses the importance of the simple but fundamental concept of prevention in combating antimicrobial resistance, and calls for more support for IPC and WASH in low- and middle-income countries to reduce antibiotic demand. @EdinUniUsher https://t.co/lIdFlLU7Uf
With tests in mice, researchers identify a new drug candidate delivered as a single, low dose to treat #schistosomiasis infection across the parasite's lifespan. https://t.co/GUHD6bqyKT
Applying Fc engineering, researchers fashion potent bispecific antibodies against #SARSCoV2 that can be delivered via mRNA to target multiple viral epitopes and can constrain the virusโ ability to evade recognition. @moderna_tx https://t.co/jGSIltTs3p
By parsing metabolic data from more than 18,000 participants in China, scientists have derived new โclockโ models of metabolic #aging that incorporate novel metrics linked to higher chronic disease risk and all-cause mortality. @sjtu1896 https://t.co/ezGZuVUC9a
The new issue of #ScienceTranslationalMedicine is out!
A large clinical study in China uncovers "clocks" of human aging that may predict chronic disease, a new mRNA antibody therapy could better tackle ever-evolving SARS-CoV-2 variants, and more. https://t.co/2ITHh7r2X1
Moran Amit is the 2026 recipient of the #AAAS Martin and Rose Wachtel Cancer Research Award for his research on how cancer reprograms peripheral nerves to evade immunityโand how to target this relationship to support #immunotherapy. @UTMDAnderson https://t.co/MQ6B6wqt9Y
Gut bacteria such as Lactobacillus prime intestinal epithelial cells in newborn mice to produce the antimicrobial protein calprotectin, making them less susceptible to sepsis and infection-related death. @CincyChildrens https://t.co/Q2QtoEYGyz
A topical combo of the mite-killing compound #flavesone and the ovicidal drug #abametapir quickly wipes out mites and eggs that cause #scabies with a single dose and cures infections more quickly than ivermectin in pigs. @QIMRB_Institute@DeepsDarshi https://t.co/u4pHmG5VHK
An invasion of immune cells from skull bone marrow triggers inflammation that drives cognitive and mood decline with age in adults with chronic #TBI, shows work that also identifies #fenofibrate as a promising therapy in a pilot trial. https://t.co/0oxL5V5yWD
An artificial lymph node provides a protected haven for tolerogenic dendritic cell therapy for autoimmune encephalitis in mice, with possible implications for #MultipleSclerosis therapy. https://t.co/MN8SN4qReZ
Don't miss this afternoon's prize-winning lecture from Moran Amit, winner of the 2026 AAAS Martin and Rose Wachtel Cancer Research Award.
Sign up now to attend his talk in person at the @AAAS building or via livestream: https://t.co/EQsVF4MZv2
๐ Congratulations to Moran Amit, winner of the 2026 AAAS Martin and Rose Wachtel Cancer Research Award!
Sign up now for his lecture about his prize-winning work on how cancers reprogram nerves, which is 9 October at the @AAAS building and via livestream: https://t.co/EQsVF4MZv2
With tests in mice, researchers identify a new drug candidate delivered as a single, low dose to treat #schistosomiasis infection across the parasiteโs lifespan. https://t.co/GUHD6bqyKT
The new issue of Science Translational Medicine has arrived!
This week features an essay from the winner of the 2026 AAAS Martin and Rose Wachtel Cancer Research Award, a new drug candidate for schistosomiasis, and more. https://t.co/eIirqRZn1F